IVI RMA, a leading player in reproductive medicine, acquired the North American operations of the Eugin Group for $535M. This group includes the Boston IVF fertility network and Toronto-based TRIO. These strategic additions strengthen IVI RMA's presence in North America and highlight its dedication to offering evidence-based fertility treatments that maximize success rates for as many patients as possible. The acquisition brings more than 600 employees, 13 labs, and 32 satellite offices into IVI RMA’s North American network. In addition, Boston IVF contributes valuable academic partnerships with institutions such as Harvard Medical School, Dartmouth Hitchcock Medical School, Boston University Medical Center, and Tufts Medical Center. This acquisition comes after KKR acquired IVI RMA for $3B in 2023.
Boston IVF is one of the largest and most experienced fertility networks in the United States. As one of the first private-practice IVF centers in the country, Boston IVF has grown to encompass over 30 reproductive endocrinologists across 30 centers in states including Massachusetts, Maine, New Hampshire, Rhode Island, New York, Delaware, Idaho, Indiana, North Carolina, Ohio, and Utah.
TRIO is Canada’s leading fertility clinic, with 10 locations across Ontario and over 40 years of experience in reproductive care. Housing the largest in-house fertility medical team in the country, TRIO’s 13 fertility specialists and 45+ supporting medical staff deliver exceptional care rooted in expertise and compassion.
Infertility is an issue that affects millions worldwide, and its prevalence is steadily rising. Recent data shows that approximately 1 in 6 people globally face infertility, marking a significant increase compared to previous decades. For those navigating the emotional and physical challenges of infertility, the journey can be overwhelming and deeply isolating.
IVF clinics have become an essential resource, offering hope and proven solutions to those yearning to build a family. These clinics are not just medical facilities; they are centers of care and support, staffed by compassionate professionals dedicated to guiding patients through one of the most challenging times of their lives.
We have seen an uptick in IVF clinic consolidation including CCRM’s recent acquisition of New Hope Fertility in April of this year and RMA Network’s expansion with Conceptions Reproductive Associates in 2023. Other VC backed players in the IVF clinic space include:
Kindbody, Series D - Kindbody offers comprehensive fertility and women’s health services, including IVF, egg freezing, and fertility preservation. The company has raised VC funding to create a more patient-friendly experience with clinics across major U.S. cities, focusing on improving accessibility to high-quality care.
WellNest Fertility, Series A - Wellnest is a patient-centered healthcare clinic specializing in fertility care, committed to providing accessible, compassionate, and high-quality services. Conveniently located for our community, WellNest offers affordable fertility treatments designed to prioritize patient comfort and convenience, including virtual consultations and thoughtfully designed exam rooms.
Spring Fertility, Later Stage VC - Spring Fertility is a IVF clinic network that applies cutting edge science in a comfortable space to deliver the best results.
As infertility rates continue to rise globally, the need for accessible, high-quality fertility treatments has never been greater, not just as providers of advanced medical treatments but as a source of guidance and support. With a dynamic mix of innovative newcomers and established leaders driving progress, the fertility care industry is well-equipped to meet the complex needs of its patients.
